Immunophotonics

Developer of therapeutics for the treatment of interventional immuno-oncology

placeSt. Louis, Missouri, United States calendar_todayFounded 2008 groups17 employees language immunophotonics.com

Registered entities

Social engagement

Social engagement: 1.7K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include Zubizoom.

Investor typeCountShare
Venture capital536%
Private equity17%
Angel & family office321%
Accelerator & incubator17%
Other / undisclosed429%

Recent activity

16 Jun 2026
Milestone
regulatory
19 May 2026
Event
ASCO26 Poster Session
1 May 2026
Product launch
IP-001
Coming soon